Overview

Continuous Infusion and Intermittent Bolus Adductor Canal Block for Total Knee Arthroplasty

Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
0
Participant gender:
All
Summary
The investigators believed the analgesic efficacy of adductor canal block on patients receiving total knee arthroplasty. However, the analgesic effects of different delivery regimens and duration of effects are variable. The investigators hypothesize that using continuous infusion and shorter interval bolus of local anesthetics to perform adductor canal block will reduce pain scale and opioid consumption in patients receiving total knee arthroplasty compared with longer interval bolus of local anesthetics.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Cheng-Kung University Hospital
Treatments:
Bupivacaine
Criteria
Inclusion Criteria:

- Adults receiving unilateral total knee arthroplasty under spinal anesthesia

- American society of anesthesiologists 1-3

Exclusion Criteria:

- Could not cooperate

- Allergy to medicines used in the study

- Chronic pain

- Long term opioid use

- Neuromuscular disease

- Surgical complication: massive bleeding, postoperative ICU, unanticipated procedure